328 related articles for article (PubMed ID: 11042508)
1. Clinical and biologic diversity of leukemias occurring in patients with mastocytosis.
Sperr WR; Horny HP; Lechner K; Valent P
Leuk Lymphoma; 2000 May; 37(5-6):473-86. PubMed ID: 11042508
[TBL] [Abstract][Full Text] [Related]
2. Myelomastocytic overlap syndromes: biology, criteria, and relationship to mastocytosis.
Valent P; Sperr WR; Samorapoompichit P; Geissler K; Lechner K; Horny HP; Bennett JM
Leuk Res; 2001 Jul; 25(7):595-602. PubMed ID: 11377685
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic criteria and classification of mastocytosis: a consensus proposal.
Valent P; Horny HP; Escribano L; Longley BJ; Li CY; Schwartz LB; Marone G; Nuñez R; Akin C; Sotlar K; Sperr WR; Wolff K; Brunning RD; Parwaresch RM; Austen KF; Lennert K; Metcalfe DD; Vardiman JW; Bennett JM
Leuk Res; 2001 Jul; 25(7):603-25. PubMed ID: 11377686
[TBL] [Abstract][Full Text] [Related]
4. Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal.
Valent P; Sotlar K; Sperr WR; Escribano L; Yavuz S; Reiter A; George TI; Kluin-Nelemans HC; Hermine O; Butterfield JH; Hägglund H; Ustun C; Hornick JL; Triggiani M; Radia D; Akin C; Hartmann K; Gotlib J; Schwartz LB; Verstovsek S; Orfao A; Metcalfe DD; Arock M; Horny HP
Ann Oncol; 2014 Sep; 25(9):1691-1700. PubMed ID: 24675021
[TBL] [Abstract][Full Text] [Related]
5. Mastocytosis: state of the art.
Horny HP; Sotlar K; Valent P
Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
[TBL] [Abstract][Full Text] [Related]
6. Ph-Chromosome-positive chronic myeloid leukemia with associated bone marrow mastocytosis.
Agis H; Sotlar K; Valent P; Horny HP
Leuk Res; 2005 Oct; 29(10):1227-32. PubMed ID: 16111540
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings.
Horny HP; Valent P
Leuk Res; 2001 Jul; 25(7):543-51. PubMed ID: 11377679
[TBL] [Abstract][Full Text] [Related]
8. Kit ligand/mast cell growth factor-independent differentiation of mast cells in myelodysplasia and chronic myeloid leukemic blast crisis.
Valent P; Spanblöchl E; Bankl HC; Sperr WR; Marosi C; Pirc-Danoewinata H; Virgolini I; Eichler HG; Agis H; Sillaber C
Blood; 1994 Dec; 84(12):4322-32. PubMed ID: 7527672
[TBL] [Abstract][Full Text] [Related]
9. De novo mast cell leukemia without CD25 expression and KIT mutations: a rare case report in a 13-year-old child.
Zheng Y; Nong L; Liang L; Wang W; Li T
Diagn Pathol; 2018 Feb; 13(1):14. PubMed ID: 29458385
[TBL] [Abstract][Full Text] [Related]
10. The tryptase positive compact round cell infiltrate of the bone marrow (TROCI-BM): a novel histopathological finding requiring the application of lineage specific markers.
Horny HP; Sotlar K; Stellmacher F; Krokowski M; Agis H; Schwartz LB; Valent P
J Clin Pathol; 2006 Mar; 59(3):298-302. PubMed ID: 16505282
[TBL] [Abstract][Full Text] [Related]
11. Myelomastocytic leukemia: histopathological features, diagnostic criteria and differential diagnosis.
Horny HP; Sotlar K; Reiter A; Valent P
Expert Rev Hematol; 2014 Aug; 7(4):431-7. PubMed ID: 25025369
[TBL] [Abstract][Full Text] [Related]
12. Detection of c-kit mutation Asp 816 to Val in microdissected bone marrow infiltrates in a case of systemic mastocytosis associated with chronic myelomonocytic leukaemia.
Sotlar K; Marafioti T; Griesser H; Theil J; Aepinus C; Jaussi R; Stein H; Valent P; Horny HP
Mol Pathol; 2000 Aug; 53(4):188-93. PubMed ID: 11040941
[TBL] [Abstract][Full Text] [Related]
13. Rapid engraftment of mast cells of donor origin in a case of acute myeloid leukemia with mast cell leukemia after allogeneic stem cell transplantation.
Chen TY; Chen JS; Huang WT; Su WC; Tsao CJ
Bone Marrow Transplant; 2003 Jul; 32(1):111-4. PubMed ID: 12815487
[TBL] [Abstract][Full Text] [Related]
14. Systemic mastocytosis associated with acute myeloid leukaemia: report of two cases and detection of the c-kit mutation Asp-816 to Val.
Sperr WR; Walchshofer S; Horny HP; Födinger M; Simonitsch I; Fritsche-Polanz R; Schwarzinger I; Tschachler E; Sillaber C; Hagen W; Geissler K; Chott A; Lechner K; Valent P
Br J Haematol; 1998 Dec; 103(3):740-9. PubMed ID: 9858225
[TBL] [Abstract][Full Text] [Related]
15. The Spectrum of Aggressive Mastocytosis: A Workshop Report and Literature Review.
Leguit R; Hebeda K; Kremer M; van der Walt J; Gianelli U; Tzankov A; Orazi A
Pathobiology; 2020; 87(1):2-19. PubMed ID: 31802761
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of neoplastic human mast cells by tryptase-immunoelectron microscopy.
Samorapoompichit P; Schernthaner GH; Worda C; Wimazal F; Krauth MT; Sperr WR; Valent P
Histopathology; 2006 Feb; 48(3):247-57. PubMed ID: 16430471
[TBL] [Abstract][Full Text] [Related]
17. Myelomastocytic leukemia versus mast cell leukemia versus systemic mastocytosis associated with acute myeloid leukemia: a diagnostic challenge.
Arredondo AR; Gotlib J; Shier L; Medeiros B; Wong K; Cherry A; Corless C; Arber DA; Valent P; George TI
Am J Hematol; 2010 Aug; 85(8):600-6. PubMed ID: 20658589
[No Abstract] [Full Text] [Related]
18. [Mastocytosis, classification, biological diagnosis and therapy].
Arock M
Ann Biol Clin (Paris); 2004; 62(6):657-69. PubMed ID: 15563424
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms.
Valent P; Sperr WR; Schwartz LB; Horny HP
J Allergy Clin Immunol; 2004 Jul; 114(1):3-11; quiz 12. PubMed ID: 15241337
[TBL] [Abstract][Full Text] [Related]
20. Systemic mastocytosis in adults: 2012 Update on diagnosis, risk stratification, and management.
Pardanani A
Am J Hematol; 2012 Apr; 87(4):401-11. PubMed ID: 22410759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]